BeStock  
Stocks › Biotechnology › SYRE

Spyre Therapeutics SYRE

US equityMarket cap rank #1512Biotechnology
$93.47 −$4.16 (-4.26%)
Market closed · Nov 22, 5:50 am ET · Last extended-hours $93.47 0.00%
Open$95.93
Prev close$97.63
Day range$93.22 – $99.56
Volume805.4K
Market cap$8.88B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts13
Average target$123.38+32.0% vs. price
  • Buy 100%
Low $115.00Now $93.47Avg $123.38High $135.00

Recent rating changes

The last 20 actions on file set price targets from $110.00 to $135.00, averaging $121.60.

DateFirmRatingTarget
12 Nov 2026 J.P. Morgan BUY $116.00
5 Nov 2026 Wells Fargo BUY $115.00
4 Nov 2026 Wells Fargo BUY $115.00
4 Nov 2026 JonesTrading BUY $130.00
4 Nov 2026 BTIG BUY $121.00
4 Nov 2026 Wedbush BUY $120.00
4 Nov 2026 Stifel BUY $131.00
3 Nov 2026 Guggenheim BUY $135.00
21 Oct 2026 Citi BUY $119.00
20 Oct 2026 Citi BUY $119.00
19 Oct 2026 BTIG BUY $121.00
19 Oct 2026 Wedbush BUY $123.00
12 Oct 2026 UBS BUY $120.00
11 Oct 2026 UBS BUY $120.00
2 Oct 2026 Wells Fargo BUY $115.00
1 Oct 2026 JonesTrading BUY $130.00
1 Oct 2026 J.P. Morgan BUY $110.00
27 Sep 2026 JonesTrading BUY $121.00
10 Sep 2026 Leerink Partners BUY $128.00
9 Sep 2026 Wedbush BUY $123.00

Discussion

No comments yet — be the first to weigh in on SYRE.

Sign in to join the discussion.

Scroll to Top